Announcements Trials

Browse Landscape

Phase

Phase 2 37 Phase 1 32 Phase 1/2 25 Phase 3 4 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Skin Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Melanoma 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Recurrence 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 Mouth Neoplasms 1 Malignant Ascites 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Small Cell 1 Carcinoma, Endometrioid 1 Carcinoma 1

Interventions

Blood Specimen Collection 15 Exercise 11 Standard of Care 9 Behavior Therapy 8 Surveys and Questionnaires 7 Palliative Care 7 Carboplatin 7 Methods 6 Early Intervention, Educational 6 Surgical Procedures, Operative 5 Practice Guidelines as Topic 5 Paclitaxel 5 Interviews as Topic 5 Educational Status 5 Diet Therapy 5 Specimen Handling 4 Salpingectomy 4 Hyperthermic Intraperitoneal Chemotherapy 4 Genetic Testing 4 Genetic Counseling 4 Drug Therapy 4 Counseling 4 Yoga 3 Psychiatric Rehabilitation 3 Music Therapy 3 Magnetic Resonance Spectroscopy 3 Laparoscopy 3 Diathermy 3 Cytoreduction Surgical Procedures 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Ovarian Neoplasms × pembrolizumab × Clear all

NCT05368207 2024-03-13

Pemb-HT

University Health Network, Toronto

Phase NA Unknown

Ovarian Neoplasms, Carcinoma, Small Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡